The Russian Company has selected Stratesys GxP Suite, an industry solution for quality management process automation, developed by the spanish system integrator as an add-on to the Opentext enterpise information management platform.

BIOCAD, one of Russia’s largest vertically integrated pharmaceutical and biotechnology companies, and manufacturer of the COVID-19 vaccine Sputnik, has selected the spanish multinational Stratesys, to modernize the quality management system applications  with the implementation of all the modules that are currently included in GxP Suite, designed by Stratesys to automate the product development and quality management systems of Life Science and Pharmaceutical organizations.

This solution adoption is part of the transformation program launched by the company that pursues, amongst other goals, improve the quality control of their production systems, simplify their product registry procedures to help their entry in new markets, enable compliance with local and international regulations regarding general manufacturing procedures, consolidate the clinical trial related information within their R&D group and digitize their laboratory procedures.

Within the framework of this innovation strategy, BIOCAD has selected Opentext Extended ECM as the core solution for Enterprise Information Management and is leveraging it’s technology to deploy several applications for other corporate departments so that content is brought in context of the corporate processes.

Mikhail Martynov, BIOCAD’s Vice president of Information technology, states that “ We selected Stratesys GxP Suite because we found a trusted partner that shared our vision and could support us on the way of global technological leading in the biotechnology area. This project is one of the set, we have selected as an IT technology base to develop our strategy. GxP suite is one one the best on the market and, taking into account integration with other products, we have chosen, it might be the best choice for us and on our tranformation way.

The Managing Partner of the Life Science Industry, Luis Fernández-Sanguino Peña, highlights the “with over 25.000 users in more than 15 countries, GxP Suite is proving it’s value added for the life science industry and we’re proud to welcome BIOCAD as a strategic customer for our growth in the GIS region”.